Loading...
Header Logo
Keywords
Last Name
Institution

Ellen Gravallese

Concepts (288)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
26
2020
214
7.630
Why?
Bone Resorption
10
2015
39
3.710
Why?
Osteoclasts
12
2015
56
2.090
Why?
Arthritis, Experimental
8
2016
34
1.990
Why?
Osteoblasts
7
2015
155
1.880
Why?
Bone Remodeling
3
2014
26
1.190
Why?
Cytokines
8
2015
717
1.130
Why?
RNA
2
2020
282
0.980
Why?
Inflammation
8
2014
651
0.970
Why?
Bone and Bones
7
2014
105
0.960
Why?
Bone Density
3
2017
134
0.950
Why?
Tumor Necrosis Factor-alpha
7
2017
490
0.880
Why?
Spondylarthropathies
2
2010
5
0.830
Why?
Teriparatide
1
2017
4
0.800
Why?
Bone Diseases, Metabolic
1
2017
23
0.790
Why?
Bone Density Conservation Agents
1
2017
45
0.770
Why?
Autoantibodies
3
2015
117
0.760
Why?
Osteogenesis
4
2012
87
0.760
Why?
Endodeoxyribonucleases
3
2016
34
0.750
Why?
Wnt Proteins
3
2012
93
0.750
Why?
Toll-Like Receptors
2
2015
423
0.700
Why?
Joints
4
2012
24
0.660
Why?
Spondylitis, Ankylosing
2
2014
16
0.660
Why?
Antibody Formation
1
2014
103
0.650
Why?
Rheumatology
2
2003
30
0.580
Why?
Inflammation Mediators
4
2015
133
0.580
Why?
DNA-Binding Proteins
4
2014
1002
0.570
Why?
Methotrexate
1
2011
71
0.520
Why?
Animals
23
2016
14740
0.510
Why?
Antirheumatic Agents
5
2017
114
0.500
Why?
Humans
29
2020
33464
0.480
Why?
Bone Diseases
1
2009
20
0.450
Why?
Osteoporosis, Postmenopausal
1
2009
62
0.440
Why?
Sialoglycoproteins
2
2004
20
0.380
Why?
Mice
15
2016
7406
0.360
Why?
Disease Models, Animal
7
2016
1198
0.350
Why?
Lupus Erythematosus, Systemic
1
2005
69
0.340
Why?
Severity of Illness Index
5
2017
841
0.340
Why?
Arthritis
3
2015
37
0.330
Why?
Signal Transduction
7
2015
2274
0.330
Why?
Autoimmunity
2
2016
141
0.330
Why?
Glycoproteins
4
2009
172
0.320
Why?
Diphosphonates
1
2004
31
0.320
Why?
Treatment Outcome
6
2017
2592
0.320
Why?
Peer Review, Research
1
2003
31
0.290
Why?
Conflict of Interest
1
2003
25
0.290
Why?
Disclosure
1
2003
34
0.290
Why?
Truth Disclosure
1
2003
45
0.290
Why?
Editorial Policies
1
2003
26
0.290
Why?
Mice, Inbred C57BL
8
2016
2300
0.280
Why?
Societies, Medical
1
2003
154
0.270
Why?
Receptors, Tumor Necrosis Factor
5
2005
62
0.270
Why?
Mice, Knockout
6
2016
1616
0.260
Why?
Membrane Glycoproteins
4
2015
619
0.250
Why?
Cell Differentiation
4
2014
1032
0.250
Why?
Radiography
2
2013
302
0.240
Why?
Intercellular Signaling Peptides and Proteins
2
2012
101
0.240
Why?
Receptors, Cytoplasmic and Nuclear
3
2005
118
0.230
Why?
Toll-Like Receptor 7
2
2015
67
0.210
Why?
Proto-Oncogene Proteins
3
2005
272
0.200
Why?
Ulna
1
2017
4
0.200
Why?
Radius
1
2017
6
0.200
Why?
Metacarpophalangeal Joint
1
2017
4
0.200
Why?
Female
10
2017
18403
0.200
Why?
Cohort Studies
2
2013
1363
0.200
Why?
Middle Aged
8
2017
9665
0.190
Why?
Osteoprotegerin
3
2005
9
0.190
Why?
Carrier Proteins
3
2014
614
0.180
Why?
Interleukin-1beta
2
2015
184
0.180
Why?
Male
10
2017
16904
0.180
Why?
Hand Bones
1
2016
2
0.180
Why?
Hand Joints
1
2016
2
0.180
Why?
Aged
5
2017
7462
0.180
Why?
Stromal Cells
1
2016
50
0.180
Why?
Toll-Like Receptor 3
1
2015
59
0.180
Why?
Interferon Regulatory Factors
1
2015
39
0.170
Why?
Adaptor Proteins, Vesicular Transport
1
2015
76
0.170
Why?
Phenotype
2
2015
781
0.170
Why?
Myeloid Cells
1
2015
54
0.170
Why?
Toll-Like Receptor 5
1
2014
9
0.170
Why?
Tomography, X-Ray Computed
2
2017
842
0.160
Why?
Myeloid Progenitor Cells
1
2014
13
0.160
Why?
Acid Phosphatase
2
2012
9
0.160
Why?
Endosomes
1
2015
139
0.160
Why?
Peritonitis
1
2014
22
0.160
Why?
Peritoneum
1
2014
28
0.160
Why?
Hematopoietic Stem Cells
1
2016
209
0.160
Why?
Blood Sedimentation
1
2014
9
0.160
Why?
Cluster Analysis
1
2014
198
0.160
Why?
Collagen Type II
1
2014
10
0.160
Why?
Nephrogenic Fibrosing Dermopathy
1
2014
21
0.160
Why?
Autoantigens
1
2014
93
0.160
Why?
Isoenzymes
2
2012
132
0.160
Why?
Gadolinium
1
2014
54
0.160
Why?
Interleukin-1
3
2003
147
0.150
Why?
Receptor Activator of Nuclear Factor-kappa B
3
2014
11
0.150
Why?
DNA
2
2015
612
0.150
Why?
RANK Ligand
3
2014
25
0.150
Why?
Immunohistochemistry
4
2009
752
0.150
Why?
C-Reactive Protein
1
2014
164
0.140
Why?
Synovial Membrane
2
2003
20
0.140
Why?
Macrophages
3
2014
731
0.140
Why?
Mice, Transgenic
3
2012
948
0.140
Why?
Contrast Media
1
2014
232
0.140
Why?
Hip Joint
2
2009
24
0.140
Why?
Terminology as Topic
1
2013
102
0.140
Why?
Bone Regeneration
1
2012
9
0.140
Why?
Gene Expression Profiling
1
2014
468
0.140
Why?
Follistatin-Related Proteins
1
2012
19
0.140
Why?
Transcription Factors
3
2005
1203
0.140
Why?
Collagen
3
2014
119
0.130
Why?
In Situ Hybridization
2
2009
195
0.130
Why?
DNA Primers
2
2009
301
0.130
Why?
Drug Therapy, Combination
1
2011
339
0.120
Why?
RNA, Messenger
6
2006
1248
0.120
Why?
Metacarpal Bones
1
2009
1
0.120
Why?
Immunity, Innate
1
2014
540
0.120
Why?
Calcification, Physiologic
1
2009
12
0.120
Why?
Spondylarthritis
1
2009
4
0.120
Why?
Rheumatic Diseases
1
2009
21
0.110
Why?
Hand
1
2009
39
0.110
Why?
Spine
1
2009
40
0.110
Why?
Base Sequence
2
2009
1246
0.110
Why?
Monocytes
2
2014
303
0.110
Why?
Antibodies
2
2014
151
0.110
Why?
Linear Models
1
2009
331
0.110
Why?
Polymerase Chain Reaction
1
2009
438
0.100
Why?
Chondrocytes
2
2005
41
0.100
Why?
Cartilage
2
2005
24
0.100
Why?
Fractures, Bone
1
2009
113
0.100
Why?
Health Surveys
1
2009
259
0.100
Why?
Mice, Inbred DBA
3
2014
83
0.100
Why?
NF-kappa B
2
2014
388
0.100
Why?
Longitudinal Studies
1
2009
675
0.100
Why?
Multivariate Analysis
1
2009
712
0.100
Why?
Osteopontin
2
2004
18
0.100
Why?
Cathepsins
2
2006
29
0.090
Why?
Osteolysis
1
2006
20
0.090
Why?
Prosthesis Implantation
1
2006
20
0.090
Why?
Clinical Trials as Topic
2
2011
291
0.090
Why?
Parathyroid Hormone-Related Protein
1
2005
7
0.090
Why?
Arthroplasty, Replacement
1
2006
17
0.090
Why?
Prostaglandins
1
2005
32
0.090
Why?
Collagenases
1
2005
15
0.090
Why?
Synovial Fluid
2
2015
26
0.090
Why?
Enzyme Induction
1
2005
36
0.090
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
27
0.090
Why?
Osteoarthritis
2
2003
31
0.090
Why?
Disease Progression
2
2004
471
0.080
Why?
Lipopolysaccharides
2
2005
519
0.080
Why?
Membrane Transport Proteins
2
2016
100
0.080
Why?
Gene Expression Regulation, Enzymologic
1
2005
117
0.080
Why?
Imidazoles
1
2004
56
0.080
Why?
Angiopoietin-1
1
2004
2
0.080
Why?
Autoimmune Diseases
1
2004
155
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2005
221
0.080
Why?
Transcription, Genetic
2
2004
782
0.070
Why?
Still's Disease, Adult-Onset
1
2002
2
0.070
Why?
Image Processing, Computer-Assisted
2
2016
425
0.070
Why?
Epitopes
1
2003
249
0.070
Why?
Risk Factors
1
2009
2937
0.070
Why?
Trans-Activators
1
2003
282
0.060
Why?
Immunoglobulin G
1
2002
334
0.060
Why?
Receptors, Interleukin-1
2
2015
64
0.060
Why?
Proto-Oncogene Proteins c-ets
3
2005
19
0.060
Why?
Cells, Cultured
3
2014
1805
0.060
Why?
Oligonucleotide Array Sequence Analysis
3
2005
268
0.060
Why?
Phosphorylation
2
2014
670
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
519
0.050
Why?
Promoter Regions, Genetic
3
2005
576
0.050
Why?
Gene Expression Regulation
1
2004
1235
0.050
Why?
Membrane Proteins
2
2016
650
0.040
Why?
Radiation Chimera
1
2016
55
0.040
Why?
Hematopoiesis, Extramedullary
1
2015
5
0.040
Why?
Splenomegaly
1
2015
15
0.040
Why?
Receptor, Interferon alpha-beta
1
2015
32
0.040
Why?
Adult
4
2016
9425
0.040
Why?
Cell Line
3
2005
1759
0.040
Why?
Gene Knockdown Techniques
1
2015
140
0.040
Why?
Flagellin
1
2014
8
0.040
Why?
Toll-Like Receptor 2
1
2015
233
0.040
Why?
Toll-Like Receptor 9
1
2015
156
0.040
Why?
Cathepsin K
2
2006
7
0.040
Why?
Luciferases
2
2005
103
0.040
Why?
Ligands
1
2015
343
0.040
Why?
Toll-Like Receptor 4
1
2015
303
0.040
Why?
Gadolinium DTPA
1
2014
51
0.040
Why?
X-Ray Microtomography
1
2014
12
0.040
Why?
Genotype
1
2015
471
0.040
Why?
Genes, Reporter
2
2005
191
0.040
Why?
Histocytochemistry
1
2014
46
0.040
Why?
Streptomycin
1
1973
10
0.040
Why?
United States
1
2003
3926
0.040
Why?
Hearing Disorders
1
1973
2
0.040
Why?
Acute-Phase Proteins
1
2014
32
0.040
Why?
Organometallic Compounds
1
2014
65
0.040
Why?
JNK Mitogen-Activated Protein Kinases
1
2014
118
0.040
Why?
Flow Cytometry
1
2016
608
0.040
Why?
Hindlimb
1
2014
42
0.040
Why?
Vertigo
1
1973
14
0.040
Why?
Apoptosis Regulatory Proteins
1
2014
113
0.040
Why?
Vision Disorders
1
1973
21
0.040
Why?
Up-Regulation
2
2005
320
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2014
146
0.040
Why?
Random Allocation
1
2014
162
0.040
Why?
Blotting, Western
2
2005
543
0.040
Why?
Antigens, CD
2
2006
288
0.040
Why?
Reproducibility of Results
1
2016
961
0.040
Why?
Cell Movement
1
2014
338
0.040
Why?
Fibroblasts
2
2004
286
0.030
Why?
Arthrography
1
2011
3
0.030
Why?
Registries
1
2014
457
0.030
Why?
Remission Induction
1
2011
88
0.030
Why?
Time Factors
2
2009
2584
0.030
Why?
Pain Measurement
1
2011
187
0.030
Why?
Recovery of Function
1
2011
146
0.030
Why?
Epidemiologic Methods
1
2009
65
0.030
Why?
Absorptiometry, Photon
1
2009
58
0.030
Why?
Osteitis
1
2009
1
0.030
Why?
Lumbar Vertebrae
1
2009
64
0.030
Why?
Patient Satisfaction
1
2011
256
0.030
Why?
Health Status
1
2011
306
0.030
Why?
Postmenopause
1
2009
216
0.030
Why?
Outcome Assessment (Health Care)
1
2011
421
0.030
Why?
Quality of Life
1
2011
415
0.030
Why?
Mutation
2
2005
1735
0.030
Why?
Receptors, Calcitonin
1
2006
1
0.020
Why?
Age Factors
1
2009
1070
0.020
Why?
Antigens, Differentiation, Myelomonocytic
1
2006
18
0.020
Why?
Fos-Related Antigen-2
1
2005
1
0.020
Why?
Matrix Metalloproteinase 13
1
2005
4
0.020
Why?
Smad1 Protein
1
2005
6
0.020
Why?
Cross-Sectional Studies
1
2009
1189
0.020
Why?
Proto-Oncogene Proteins c-jun
1
2005
23
0.020
Why?
Tibia
1
2005
31
0.020
Why?
Femur
1
2005
30
0.020
Why?
Bone Morphogenetic Protein 2
1
2005
43
0.020
Why?
Bone Morphogenetic Proteins
1
2005
46
0.020
Why?
NFATC Transcription Factors
1
2005
17
0.020
Why?
Bone Development
1
2005
32
0.020
Why?
Immunoprecipitation
1
2005
122
0.020
Why?
Cyclooxygenase 2
1
2005
54
0.020
Why?
Plasmids
1
2005
246
0.020
Why?
Transforming Growth Factor beta
1
2005
141
0.020
Why?
Core Binding Factor Alpha 1 Subunit
1
2005
134
0.020
Why?
Chemotaxis
1
2004
38
0.020
Why?
Transcription Factor AP-1
1
2004
40
0.020
Why?
NIH 3T3 Cells
1
2004
86
0.020
Why?
DNA Mutational Analysis
1
2004
140
0.020
Why?
Transfection
1
2005
640
0.020
Why?
DNA, Complementary
1
2004
183
0.020
Why?
Cell Cycle
1
2005
339
0.020
Why?
Oligonucleotide Probes
1
2003
43
0.020
Why?
DNA Damage
1
2005
239
0.020
Why?
Immunoenzyme Techniques
1
2003
107
0.020
Why?
Mutagenesis, Site-Directed
1
2004
254
0.020
Why?
Oligonucleotides
1
2004
100
0.020
Why?
Blotting, Northern
1
2003
156
0.020
Why?
Tarsus, Animal
1
2002
1
0.020
Why?
Transcriptional Activation
1
2004
202
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2002
20
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2002
32
0.020
Why?
Immunization, Passive
1
2002
84
0.020
Why?
Endopeptidases
1
2002
63
0.020
Why?
Binding Sites
1
2004
759
0.020
Why?
Interleukin-6
1
2002
230
0.020
Why?
Cell Line, Tumor
1
2004
836
0.020
Why?
RNA, Small Interfering
1
2005
586
0.020
Why?
Pilot Projects
1
2002
481
0.020
Why?
Molecular Sequence Data
1
2005
2071
0.020
Why?
Genetic Vectors
1
2004
515
0.010
Why?
Apoptosis
1
2005
860
0.010
Why?
Protein Binding
1
2004
1225
0.010
Why?
Nuclear Proteins
1
2005
687
0.010
Why?
Genetic Predisposition to Disease
1
2002
426
0.010
Why?
Tooth Extraction
1
1968
5
0.010
Why?
Surgical Wound Infection
1
1968
60
0.010
Why?
Anti-Bacterial Agents
1
1968
375
0.010
Why?
Ear, Inner
1
1973
4
0.010
Why?
Tuberculosis
1
1973
121
0.010
Why?
Child, Preschool
1
1973
1281
0.010
Why?
Child
1
1973
2586
0.010
Why?
Adolescent
1
1973
3894
0.010
Why?
Polymyxins
1
1968
1
0.000
Why?
Tyrothricin
1
1968
1
0.000
Why?
Tetracaine
1
1968
6
0.000
Why?
Neomycin
1
1968
8
0.000
Why?
Rats
1
1968
1773
0.000
Why?
Gravallese's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_